EGFR mutations in malignant pleural effusion of non-small cell lung cancer: A case report

Ming Jer Huang, Ken Hong Lim, Chin Yuan Tzen, Han Shui Hsu, Yun Yen, Biing Shiun Huang

研究成果: 雜誌貢獻文章

15 引文 斯高帕斯(Scopus)

摘要

EGFR mutations have been shown to correlate with the clinical responsiveness to epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). The detection of EGFR mutations in non-small cell lung cancer (NSCLC) is important from the perspective of targeted anticancer therapy. We report the first case showing that the status of EGFR mutations can be successfully determined in malignant pleural effusion of NSCLC using polymerase chain reaction (PCR) technique, and correlated to the clinical responsiveness to gefitinib, an EGFR-TKI. This case demonstrated the importance of molecular cytology in the era of targeted therapy.

原文英語
頁(從 - 到)413-415
頁數3
期刊Lung Cancer
49
發行號3
DOIs
出版狀態已發佈 - 九月 1 2005
對外發佈Yes

ASJC Scopus subject areas

  • Oncology

指紋 深入研究「EGFR mutations in malignant pleural effusion of non-small cell lung cancer: A case report」主題。共同形成了獨特的指紋。

  • 引用此